{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:26:20Z","timestamp":1779200780217,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1245\/s10434-021-09692-7","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T19:26:18Z","timestamp":1620069978000},"page":"7487-7495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Contralateral Suppression Index Does Not Predict Clinical Cure in Patients Undergoing Surgery for Primary Aldosteronism"],"prefix":"10.1245","volume":"28","author":[{"given":"Dana A.","family":"Dominguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Chatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy R.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira M.","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady","family":"Hannah-Shmouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"issue":"14","key":"9692_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69(14):1811\u201320.","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"9692_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0031-1295438","volume":"44","author":"A Hannemann","year":"2012","unstructured":"Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2014a review of the current literature. Horm Metab Res. 2012;44(3):157\u201362.","journal-title":"Horm Metab Res."},{"issue":"1","key":"9692_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020;173(1):10\u201320.","journal-title":"Ann Intern Med."},{"key":"9692_CR4","first-page":"1","volume":"1","author":"JB Cohen","year":"2020","unstructured":"Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. veterans: a retrospective cohort study. Ann Intern Med. 2020;1:1.","journal-title":"Ann Intern Med."},{"issue":"6","key":"9692_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/er.2018-00139","volume":"39","author":"A Vaidya","year":"2018","unstructured":"Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev. 2018;39(6):1057\u201388.","journal-title":"Endocr Rev."},{"issue":"11","key":"9692_CR6","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1210\/jc.2014-2345","volume":"99","author":"S Monticone","year":"2014","unstructured":"Monticone S, Satoh F, Viola A, et al. Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. J Clin Endocrinol Metab. 2014;99(11):4158\u2013166.","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"9692_CR7","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1530\/EJE-20-0863","volume":"183","author":"GL Hundemer","year":"2020","unstructured":"Hundemer GL, Vaidya A. Management of endocrine disease: the role of surgical adrenalectomy in primary aldosteronism. Eur J Endocrinol. 2020;183(6):R185\u201396.","journal-title":"Eur J Endocrinol."},{"key":"9692_CR8","first-page":"1","volume":"1","author":"AF Turcu","year":"2020","unstructured":"Turcu AF, Auchus R. Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling. J Clin Endocrinol Metab. 2020;1:1.","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"9692_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa606","volume":"105","author":"A Vaidya","year":"2020","unstructured":"Vaidya A, Carey RM. Evolution of the Primary Aldosteronism Syndrome: Updating the Approach. J Clin Endocrinol Metab. 2020;105(12):1.","journal-title":"J Clin Endocrinol Metab."},{"key":"9692_CR10","doi-asserted-by":"crossref","unstructured":"Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u20131916.","DOI":"10.1210\/jc.2015-4061"},{"issue":"7","key":"9692_CR11","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/jhh.2016.92","volume":"31","author":"M Tagawa","year":"2017","unstructured":"Tagawa M, Ghosn M, Wachtel H, et al. Lateralization index but not contralateral suppression at adrenal vein sampling predicts improvement in blood pressure after adrenalectomy for primary aldosteronism. J Hum Hypertens. 2017;31(7):444\u2013449.","journal-title":"J Hum Hypertens."},{"issue":"3","key":"9692_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","volume":"247","author":"R Zarnegar","year":"2008","unstructured":"Zarnegar R, Young WF Jr, Lee J, et al. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg. 2008;247(3):511\u201318.","journal-title":"Ann Surg."},{"issue":"4","key":"9692_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/bjs.9744","volume":"102","author":"A Muth","year":"2015","unstructured":"Muth A, Ragnarsson O, Johannsson G, Wangberg B. Systematic review of surgery and outcomes in patients with primary aldosteronism. Br J Surg. 2015;102(4):307\u201317.","journal-title":"Br J Surg."},{"key":"9692_CR14","first-page":"1","volume":"1","author":"J Burrello","year":"2019","unstructured":"Burrello J, Burrello A, Stowasser M, et al. The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism. Ann Surg. 2019;1:1.","journal-title":"Ann Surg."},{"issue":"3","key":"9692_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jamcollsurg.2010.05.006","volume":"211","author":"A Mathur","year":"2010","unstructured":"Mathur A, Kemp CD, Dutta U, et al. Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease. J Am Coll Surg. 2010;211(3):384\u201390.","journal-title":"J Am Coll Surg."},{"issue":"1","key":"9692_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63(1):151\u201360.","journal-title":"Hypertension."},{"issue":"8","key":"9692_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1210\/js.2018-00055","volume":"2","author":"H Umakoshi","year":"2018","unstructured":"Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, et al. Correlation between lateralization index of adrenal venous sampling and standardized outcome in primary aldosteronism. J Endocr Soc. 2018;2(8):893\u2013902.","journal-title":"J Endocr Soc."},{"issue":"4","key":"9692_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/cen.12761","volume":"83","author":"H Umakoshi","year":"2015","unstructured":"Umakoshi H, Tanase-Nakao K, Wada N, et al. Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism. Clin Endocrinol (Oxf). 2015;83(4):462\u201367.","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"9692_CR19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1210\/jc.2014-3676","volume":"100","author":"MJ Wolley","year":"2015","unstructured":"Wolley MJ, Gordon RD, Ahmed AH, Stowasser M. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Clin Endocrinol Metab. 2015;100(4):1477\u201384.","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"9692_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5(9):689\u201399.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"9692_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers MJ, Lenders JW, van Outheusden L, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Int Med. 2009;151(5):329\u201337.","journal-title":"Ann Int Med."},{"issue":"4","key":"9692_CR22","doi-asserted-by":"publisher","first-page":"e185842","DOI":"10.1001\/jamasurg.2018.5842","volume":"154","author":"W Vorselaars","year":"2019","unstructured":"Vorselaars W, Nell S, Postma EL, et al. Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism. JAMA Surg. 2019;154(4):e185842.","journal-title":"JAMA Surg."},{"issue":"3","key":"9692_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.surg.2011.08.001","volume":"151","author":"T Utsumi","year":"2012","unstructured":"Utsumi T, Kawamura K, Imamoto T, et al. High predictive accuracy of Aldosteronoma Resolution Score in Japanese patients with aldosterone-producing adenoma. Surgery. 2012;151(3):437\u201343.","journal-title":"Surgery."},{"issue":"10","key":"9692_CR24","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00268-019-05074-z","volume":"43","author":"W Vorselaars","year":"2019","unstructured":"Vorselaars W, van Beek DJ, Postma EL, et al. Validation of the aldosteronoma resolution score within current clinical practice. World J Surg. 2019;43(10):2459\u201368.","journal-title":"World J Surg."},{"issue":"1","key":"9692_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.surg.2017.07.034","volume":"163","author":"OA Shariq","year":"2018","unstructured":"Shariq OA, Bancos I, Cronin PA, et al. Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism. Surgery. 2018;163(1):183\u2013190.","journal-title":"Surgery."},{"issue":"5","key":"9692_CR26","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","volume":"51","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Bolognesi M, Rizzoni D, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008;51(5):1366\u2013373.","journal-title":"Hypertension."},{"issue":"2","key":"9692_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2217\/ije-2016-0020","volume":"4","author":"N Nilubol","year":"2017","unstructured":"Nilubol N, Soldin SJ, Patel D, et al. 11-Deoxycortisol may be superior to cortisol in confirming a successful adrenal vein catheterization without cosyntropin: a pilot study. Int J Endocr Oncol. 2017;4(2):75\u201383.","journal-title":"Int J Endocr Oncol."},{"issue":"14","key":"9692_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJM199210013271417","volume":"327","author":"M Gagner","year":"1992","unstructured":"Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing\u2019s syndrome and pheochromocytoma. N Engl J Med. 1992;327(14):1033.","journal-title":"N Engl J Med."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09692-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T20:18:35Z","timestamp":1634329115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09692-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["9692"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09692-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Stratakis holds patents on the <i>PRKAR1A<\/i>, <i>PDE11A, <\/i> and <i>GPR101<\/i> genes and\/or their function and has received research funding from Pfizer Inc. on the genetics and treatment of abnormalities of growth hormone secretion. Other authors report no relevant disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}